Immunocore at the Crossroads: Steady Hands and the Search for Tomorrow's Breakthrough

Beyond the Horizon: How Compugen's COM701 is Quietly Redefining the Battle Against Cancer

The Rocket Ride: How Intensity Therapeutics Ignited Wall Street (and Hope) with its Cancer Breakthrough

Corbus Pharmaceuticals' Lead Drug Receives Esteemed FDA Fast Track Designation

Tuhura Biosciences Shines in Q2 2025: Strong Financials and Promising Pipeline Advancements Unveiled